IRIS
MONTIRONI, Rodolfo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.256
EU - Europa 14.408
AS - Asia 6.346
AF - Africa 317
SA - Sud America 58
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 9
Totale 52.446
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.212
UA - Ucraina 3.817
SG - Singapore 2.378
IE - Irlanda 2.235
TR - Turchia 1.886
SE - Svezia 1.771
DE - Germania 1.745
DK - Danimarca 1.435
IT - Italia 1.394
CN - Cina 1.032
FI - Finlandia 779
KR - Corea 776
GB - Regno Unito 580
FR - Francia 472
CI - Costa d'Avorio 267
IN - India 134
HK - Hong Kong 70
BE - Belgio 53
EU - Europa 52
BR - Brasile 46
CA - Canada 41
RU - Federazione Russa 37
MA - Marocco 34
NL - Olanda 20
ID - Indonesia 15
VN - Vietnam 15
ES - Italia 13
JP - Giappone 13
EG - Egitto 8
CH - Svizzera 7
AU - Australia 6
RO - Romania 6
BG - Bulgaria 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CO - Colombia 4
IL - Israele 4
RS - Serbia 4
CZ - Repubblica Ceca 3
GR - Grecia 3
LU - Lussemburgo 3
MX - Messico 3
NZ - Nuova Zelanda 3
PL - Polonia 3
PT - Portogallo 3
AM - Armenia 2
AR - Argentina 2
AT - Austria 2
BO - Bolivia 2
EE - Estonia 2
HU - Ungheria 2
IQ - Iraq 2
IR - Iran 2
IS - Islanda 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
LY - Libia 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BY - Bielorussia 1
EC - Ecuador 1
HR - Croazia 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
LI - Liechtenstein 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 52.446
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.923
Chandler 3.305
Fairfield 3.242
Dublin 2.231
Boardman 2.079
Ashburn 1.916
Des Moines 1.838
Wilmington 1.762
Woodbridge 1.433
Houston 1.238
Seattle 1.207
Singapore 1.043
Cambridge 1.008
Lawrence 908
Princeton 908
San Mateo 892
New York 792
Ann Arbor 600
San Diego 419
Centro 414
Abidjan 267
Milan 237
London 150
Beijing 130
Pune 125
Shanghai 98
Norwalk 93
Washington 92
Guangzhou 87
Redmond 79
Los Angeles 76
Wuhan 74
Hong Kong 67
Izmir 67
Helsinki 65
Falls Church 61
Dallas 58
Brussels 51
Marche 48
Turin 45
Kilburn 44
Ancona 36
Jiaxing 36
Rome 36
Venice 28
Seoul 27
Porto 26
Prescot 26
Wuxi 24
Yiwu 22
New Bedfont 20
Shenzhen 20
Tappahannock 20
Chiswick 17
Ottawa 17
Berlin 16
Auburn Hills 15
Fayetteville 15
Hounslow 15
Acton 13
Dong Ket 13
Jinhua 13
Chicago 12
Bologna 11
Quanzhou 11
Wandsworth 11
Frankfurt am Main 10
Fuzhou 10
Hanover 10
Southwark 10
Edinburgh 9
Forlì 9
Nanjing 9
Pesaro 9
Phoenix 9
Sheffield 9
Simi Valley 9
Strasbourg 9
Essen 8
Redwood City 8
Amsterdam 7
Montréal 7
Palermo 7
Stockholm 7
São Paulo 7
Toronto 7
Torre Del Greco 7
Córdoba 6
Gatchina 6
Islington 6
Jinan 6
Menlo Park 6
Moscow 6
Saint Petersburg 6
Zhengzhou 6
Buffalo 5
Heze 5
Mountain View 5
Ostra Vetere 5
Santa Clara 5
Totale 33.922
Salva come PNG Salva come JPEG
Nome #
Variation in reporting of cancer extent and benign histology in prostate biopsies among European pathologists. 157
Designing novel immunocombinations in metastatic renal cell carcinoma 152
Handling and reporting of transurethral resection specimens of the bladder in Europe: a web-based survey by the European Network of Uropathology (ENUP). 138
Lymphoepithelioma-like carcinoma of the urinary bladder: a clinicopathologic study of 13 cases. 134
Mitogen-activated protein kinases and apoptosis in PIN. 133
Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis 129
OCT4: biological functions and clinical applications as a marker of germ cell neoplasia 129
Role of DNA analysis and mutation of P53 gene in small dimension renal carcinomas. Biological significance and long-term follow-up 128
Germline and somatic mutations in prostate cancer: Focus on defective DNA repair, PARP inhibitors and immunotherapy 128
Immunotherapy in genitourinary cancers: Where are we going? 122
Prostatic Intraepithelial Neoplasia - Development of A Bayesian Belief Network For Diagnosis and Grading. 120
Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients 120
Morphometric index of adult renal cell carcinoma. Comparison with the Fuhrman grading system. 117
Green fluorescent protein as indicator of non-viral transient transfection efficiency in endometrial and testicular biopsies 113
Chromosomal Abnormalities in Macroscopically Normal Urothelium in Patiens with Bladder pT1 and pT2a Urothelial Carcinoma: a Fluorescence in situ hybridisation Study and Correlation with Histologic Features. 110
Atypical foci, suspicious but not diagnostic of malignancy in prostate needle biopsies (also referred to as "atypical small acinar proliferation suspicious for but not diagnostic of malignancy") 109
Secondary neoplasms of the urinary system and male genital organs. 108
Clinical performance and utility of a NNMT-based urine test for bladder cancer 107
Microbiome and cancers, with focus on genitourinary tumors 107
Sequential or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6 Before mTOR Pathway in Hormone-Positive HER2 Negative Breast Cancer: Biological Insights and Clinical Implications 107
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 105
Metabolic phenotype of bladder cancer 105
Computer assisted discrimination of glioblastomas 104
Transcontinental communication and quantitative digital histopathology via the Internet; with special reference to prostate neoplasia 103
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 103
Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study. 103
Expression of pi-class glutathione S-transferase: two populations of high grade prostatic intraepithelial neoplasia with different relations to carcinoma 102
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in Renal Cell Carcinoma 102
Ciliary neurotrophic factor (CNTF) and its receptor (CNTFRα) signal through MAPK/ERK pathway in human prostate tissues: a morphological and biomolecular study 101
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected andreogen-dependent and androgen-independent cancer. 100
Primary B-cell lymphoblastic lymphoma of the testis 100
Tumor VEGF expression correlates with tumor stage and identifies prognostically different groups in clear cell renal cell carcinoma patients 100
BAP1, PBRM1 and SETD2 in clear-cell renal cell carcinoma: Molecular diagnostics and possible targets for personalized therapies 99
Biological issues with cabozantinib in bone metastatic renal cell carcinoma and castration-resistant prostate cancer 98
Molecular diagnostics in uro-oncology 96
Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer. 95
Cardiac myxoma with glandular elements metastatic to the brain 12 years after the removal of the original tumor 94
Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications 94
Seminal Vesicle Intraepithelial Neoplasia Versus Basal Cell Hyperplasia in a Seminal Vesicle. 93
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis 93
Cytometric Evidence That Cervical Intraepithelial Neoplasia-i and Neoplasia-ii Are Dysplasias Rather Than True Neoplasias - An Image-analysis Study of Factors Involved In the Progression of Cervical Lesions 93
Metabolic Alterations in Renal and Prostate Cancer 93
From undergraduate medical school student to visible pathologist 93
Morphologic Variants of Epithelial and Neuroendocrine Tumors of the Prostate. The Pathologist's Point of View 92
Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1) 90
alpha-methylacyl-CoA racemase (P504S)/34 beta E12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy 90
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling 90
Quantitative-analysis of Prostatic Intraepithelial Neoplasia On Tissue-sections. 90
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer. 90
Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. 89
Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading 89
Is There a Role for Immunotherapy in Prostate Cancer? 89
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review. 88
Computer assisted analysis of medulloblastoma: a cytological study 88
Urothelial papillary lesions. Development of a Bayesian Belief Network for diagnosis and grading 87
Morphological diagnosis of urothelial neoplasms. 87
Do DNA methylation and histone acetylation play a role in clear cell renal carcinoma? Analysis of radical nephrectomy specimens in a long-term follow-up. 87
2004 WHO classification of the renal tumors of the adults. 87
Succinate dehydrogenase-deficient renal cell carcinoma: Detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma 87
Oligometastases in Genitourinary Tumors: Recent Insights and Future Molecular Diagnostic Approach 87
Cognitive zonal fusion biopsy of the prostate: Original technique between target and saturation. 87
Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis 86
TGFb1 immunohistochemistry in goiter; comparison of patients with recurrence or non recurrence 86
"Pathological" reflection on European urology: extended, saturation, and systematic prostate biopsies. 86
Perivascular epithelioid cell tumor (PEC-ome) of the prostate: ultrasound feature in case report 86
Expert system support using a Bayesian belief network for the classification of endometrial hyperplasia 85
Standardized mitotic counts in breast cancer evaluation of the method 85
PD-1 blockade therapy in renal cell carcinoma: current studies and future promises 85
Grading of Chromophobe Renal Cell Carcinoma: Do We Need It? 85
Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? 84
Improving inter-observer agreement and certainty level in diagnosing and grading papillary urothelial neoplasms: usefulness of a Bayesian belief network. 84
Joint appraisal of the radical prostatectomy specimen by the urologist and the uropathologist: together, we can do it better 84
Pathology in prostate research: Optimizing tissue quality 84
Editorial comment on: validation of the contemporary epstein criteria for insignificant prostate cancer in European men. 84
D2-40 immunoreactivity in penile squamous cell carcinoma: a marker of aggressiveness 84
Clinicopathologic analysis of upper urinary tract carcinoma with variant histology 84
Combination therapy in advanced urothelial cancer: the role of PARP, HER-2 and mTOR inhibitors 84
Pd-l1 inhibitors for the treatment of prostate cancer 84
Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule 84
Statistical histometry of the basal cell secretory cell bilayer in prostatic intraepithelial neoplasia. 83
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib 83
Exploring the Spectrum of Kidney Ciliopathies 83
Predicting future cancer burden in the United States by artificial neural networks 83
Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice 83
Villous adenoma of the urinary tract: a report of 23 cases, including 8 with coexistent adenocarcinoma 82
Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. 82
[Gleason's grading of prostatic cancer: a current perspective]. 82
Impact of prostate cancer multifocality on its biology and treatment. 82
Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets 82
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 82
The 1996 European Urology Focus on Preneoplastic Lesions of the Prostate 82
HtrA1 in human urothelial bladder cancer: a secreted protein and a potential novel biomarker. 81
Epigenetic modifications and modulators in prostate cancer 81
Extent of cancer of less than 50% in any prostate needle biopsy core: how many millimeters are there? 81
Aneuploidy and nuclear features of prostatic intraepithelial neoplasia (PIN). 80
Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians 80
The human microbiota and prostate cancer: Friend or foe? 80
Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer 80
Extramammary Paget disease of the penis closely mimicking the penile analogue of stratified mucin-producing intraepithelial lesion 80
A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry 80
Totale 9.567
Salva come PNG Salva come JPEG
Categoria #
all - tutte 313.505
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 313.505
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.813 0 0 0 0 0 21 786 8 780 32 78 1.108
2020/202112.955 612 1.238 1.572 269 1.517 1.477 1.215 933 1.163 1.130 1.275 554
2021/20226.642 620 1.542 134 320 93 552 203 432 475 538 386 1.347
2022/202311.128 1.119 780 604 975 804 2.588 11 659 2.830 51 421 286
2023/20246.133 1.239 165 345 998 1.049 1.158 112 111 20 109 56 771
2024/20253.980 1.108 1.130 629 342 401 370 0 0 0 0 0 0
Totale 53.150